Company Registration No. 16159083 (England and Wales)
NEURO FX LTD
Annual Report and Statement of Accounts
For the Period from 02 January 2025 to 31 January 2026

NEURO FX LTD

Annual report and statement of accounts for the period ending 31/01/2026

NEURO FX LTD

Financial statement for the period ended 31/01/2026

Company Information

1 Statutory Information
Company Number 16159083
Registered Office CROWN HOUSE
27 OLD GLOUCESTER STREET
LONDON
UNITED KINGDOM
WC1N 3AX
2 Directors
Directors who held office during the period were:
Paul Anthony FOX   
Tina Suzanne FOX   
3 Principal Activity
Assessment, diagnosis and treatment of ADHD and autism in children aged 6 and over and adults
4 Employees
Average number of employees, including directors, during the year was as follows:
2026 0

NEURO FX LTD

Financial statement for the period ended 31/01/2026

Statement of Financial Position

2026
£
Fixed Assets -
Current Assets 36,481
Creditors: amounts falling due within one year (7,214)
Net Current Assets 29,267
Total assets less current liabilities 29,267
Creditors: amounts falling due after one year -
Net Assets 29,267
Capital and reserves 29,267
For the period ending 31/01/2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the Board on 13 May 2026
Mr Paul Fox
Company Registration No. 16159083